Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density

OBJECTIVE: To evaluate changes in bone density and architecture in postmenopausal women with breast cancer (BC) and use of aromatase inhibitor (AI). SUBJECTS AND METHODS: Thirty-four postmenopausal women with BC, without bone metastasis, renal function impairment and who were not receiving bone-acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, Frederico Arthur Pereira, de Farias, Maria Lucia Fleiuss, Oliveira, Felipe Peres, Vieira, Leonardo, Lima, Luis Felipe Cardoso, Paranhos, Francisco de Paula, de Mendonça, Laura Maria Carvalho, Madeira, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522186/
https://www.ncbi.nlm.nih.gov/pubmed/34283901
http://dx.doi.org/10.20945/2359-3997000000385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522186/
https://www.ncbi.nlm.nih.gov/pubmed/34283901
http://dx.doi.org/10.20945/2359-3997000000385

Ejemplares similares